Assessing the Risk of SARS-CoV-2 Remdesivir Resistance

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/216/30/23

Funding

  • National Institute of Allergy and Infectious Diseases (5R21AI163912-02)